AAAAAA
Results: 1-25/67
Authors:
WALSON PD
Citation: Pd. Walson, UNTITLED - COMMENT, Clinical therapeutics, 20(4), 1998, pp. 633-633
Authors:
WALSON PD
Citation: Pd. Walson, UNTITLED - COMMENT, Clinical therapeutics, 20(4), 1998, pp. 870-870
Authors:
WALSON PD
Citation: Pd. Walson, UNTITLED, Clinical therapeutics, 20(3), 1998, pp. 375-375
Authors:
WALSON PD
Citation: Pd. Walson, REVIEW ARTICLES - COMMENT, Clinical therapeutics, 20(2), 1998, pp. 215-215
Authors:
WALSON PD
Citation: Pd. Walson, UNTITLED, Clinical therapeutics, 20(2), 1998, pp. 364-364
Authors:
WALSON PD
Citation: Pd. Walson, THERAPEUTIC DRUG-MONITORING IN SPECIAL POPULATIONS, Clinical chemistry, 44(2), 1998, pp. 415-419
Authors:
WALSON PD
Citation: Pd. Walson, HYPOTHERMIA FROM AZITHROMYCIN, Journal of toxicology. Clinical toxicology, 35(5), 1997, pp. 459-459
Authors:
KELLEY MT
WALSON PD
COX S
DUSCI LJ
Citation: Mt. Kelley et al., POPULATION PHARMACOKINETICS OF FELBAMATE IN CHILDREN, Therapeutic drug monitoring, 19(1), 1997, pp. 29-36
Authors:
WALSON PD
Citation: Pd. Walson, EDITORIAL COMMENT, Clinical therapeutics, 19(6), 1997, pp. 1253-1254
Authors:
LEGUIRE LE
JENDE D
WALSON PD
ROGERS GL
BREMER DL
MCGREGOR ML
Citation: Le. Leguire et al., LONGITUDINAL-STUDY OF LEVODOPA FOR CHILDHOOD RETINAL DEGENERATION, Investigative ophthalmology & visual science, 38(4), 1997, pp. 3298-3298
Authors:
WALSON PD
Citation: Pd. Walson, TRIALS IN SPECIAL POPULATIONS, Current therapeutic research, 58(9), 1997, pp. 631-632
Authors:
WALSON PD
Citation: Pd. Walson, TRIALS IN SPECIAL POPULATIONS - EDITORIAL COMMENT, Current therapeutic research, 58(7), 1997, pp. 459-459
Authors:
WALSON PD
Citation: Pd. Walson, TRIALS IN SPECIAL POPULATIONS - EDITORIAL COMMENT, Current therapeutic research, 58(6), 1997, pp. 381-381
Authors:
WALSON PD
Citation: Pd. Walson, UNTITLED - EDITORIAL COMMENT, Current therapeutic research, 58(5), 1997, pp. 281-281
Authors:
WALSON PD
Citation: Pd. Walson, EDITORIAL COMMENT, Current therapeutic research, 58(4), 1997, pp. 213-214
Authors:
WALSON PD
Citation: Pd. Walson, EDITORIAL COMMENT, Current therapeutic research, 58(3), 1997, pp. 127-127
Authors:
WALSON PD
Citation: Pd. Walson, TRIALS IN SPECIAL POPULATIONS - EDITORIAL COMMENT, Current therapeutic research, 58(3), 1997, pp. 201-201
Authors:
WALSON PD
Citation: Pd. Walson, TRIALS IN SPECIAL POPULATIONS - EDITORIAL COMMENT, Current therapeutic research, 58(2), 1997, pp. 116-116
Authors:
WALSON PD
Citation: Pd. Walson, TRIALS IN SPECIAL POPULATIONS - EDITORIAL COMMENT, Current therapeutic research, 58(12), 1997, pp. 979-980
Authors:
WALSON PD
Citation: Pd. Walson, COMMENT, Current therapeutic research, 58(11), 1997, pp. 815-815
Authors:
WALSON PD
Citation: Pd. Walson, TRIALS IN SPECIAL POPULATIONS - COMMENT, Current therapeutic research, 58(11), 1997, pp. 893-893
Authors:
WALSON PD
Citation: Pd. Walson, UNTITLED - COMMENT, Current therapeutic research, 58(10), 1997, pp. 655-655
Authors:
WALSON PD
Citation: Pd. Walson, TRIALS IN SPECIAL POPULATIONS - COMMENT, Current therapeutic research, 58(10), 1997, pp. 797-797
Authors:
WALSON PD
Citation: Pd. Walson, TRIALS IN SPECIAL POPULATIONS - COMMENT, Current therapeutic research, 58(1), 1997, pp. 37-37
Authors:
WALSON PD
Citation: Pd. Walson, EFFECTS OF POLICOSANOL ON PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS AND HYPERCHOLESTEROLEMIA - A PILOT-STUDY - COMMENT, Current therapeutic research, 58(1), 1997, pp. 52-53